An early drug development leader with strong operational experience in the Pharmaceutical and Biotech industry, advancing biologics in Haematology/Oncology and Immune inflammation therapeutic areas into the clinic.
Have held accountability for overall project leadership, and for biology/translational areas, from project initiation to completion of Phase 1 and beyond in both patients and healthy volunteers.
Highly experienced line manager of bench scientists with responsibility for delivering IND enabling pharmacology and translational packages on immunomodulation and oncology targets.
1
article